h-header

news

News dal mondo

17

Mar

EMA Management Board: highlights of March 2026 meeting

Board adopts Agency’s 2025 annual report and notes electronic product information implementation roadmap

  • EMA annual report 2025

  • Preparations for implementation of the new EU pharmaceutical legislation

  • Electronic product information implementation roadmap

  • EMA reports on stakeholder engagement activities 2024-2025

  • Monitoring EMA’s independence policies

  • Impact of war in the Middle East

  • Executive Director vacancy notice

  • Clinical trials in the EU

30

Apr

AIFA pubblica il Terzo Position Paper sui farmaci biosimilari

È online il terzo Position Paper AIFA sui farmaci biosimilari. L’aggiornamento del documento...

29

Apr

US GDUFA IV Talks Reach Tentative Agreement; America First Application Fee Waiver Added

US FDA GDUFA Reauthorization performance goals and program enhancements Riscal years 2023-2027 - Meeting...

28

Apr

Sun Pharma compra Organon

Sun Pharmaceutical Industries ha firmato un accordo definitivo per acquisire Organon &...

27

Apr

US QMM: Participants scored well on commitment to quality, lower on advanced manufacturing

Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity...

slider-banner

h-footer